The research progress of circular RNAs in hematological malignancies

References

• Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852–3856. doi: 10.1073/pnas.73.11.3852
   PubMed Web of Science ®Google Scholar
• Shang Q, Yang Z, Jia R, et al. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6. doi: 10.1186/s12943-018-0934-6
   PubMed Web of Science ®Google Scholar
• Xu T, Wu J, Han P, et al. Circular RNA expression profiles and features in human tissues: a study using RNA-seq data. BMC Genomics. 2017;18(Suppl 6):680. doi: 10.1186/s12864-017-4029-3
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Venø MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. doi: 10.1038/onc.2017.361
   PubMed Web of Science ®Google Scholar
• Dragomir M, Calin GA. Circular RNAs in cancer – lessons learned from microRNAs. Front Oncol. 2018;8:179. doi: 10.3389/fonc.2018.00179
   PubMed Web of Science ®Google Scholar
• Chipman LB, Pasquinelli AE. miRNA targeting: growing beyond the seed. Trends Genet. 2019;35(3):215–222. doi: 10.1016/j.tig.2018.12.005
   PubMed Web of Science ®Google Scholar
• Chen H, Liu T, Liu J, et al. Circ-ANAPC7 is upregulated in acute myeloid leukemia and appears to target the MiR-181 family. Cell Physiol Biochem. 2018;47(5):1998–2007. doi: 10.1159/000491468
   PubMedGoogle Scholar
• Wu DM, Wen X, Han XR, et al. Role of circular RNA DLEU2 in human acute myeloid leukemia. Mol Cell Biol. 2018;38(20). doi:10.1128/MCB.00259-18.
   Web of Science ®Google Scholar
• Shang J, Chen WM, Wang ZH, et al. CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p-XIAP axis. Exp Hematol. 2019;70:42–54. doi: 10.1016/j.exphem.2018.10.011
   PubMed Web of Science ®Google Scholar
• Li W, Zhong C, Jiao J, et al. Characterization of hsa_circ_0004277 as a new biomarker for acute myeloid leukemia via circular RNA profile and bioinformatics analysis. Int J Mol Sci. 2017;18(3):597. doi: 10.3390/ijms18030597
   PubMed Web of Science ®Google Scholar
• Hirsch S, Blätte TJ, Grasedieck S, et al. Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia. Haematologica. 2017;102(12):2039–2047. doi: 10.3324/haematol.2017.172866
   PubMed Web of Science ®Google Scholar
• Li S, Ma Y, Tan Y, et al. Profiling and functional analysis of circular RNAs in acute promyelocytic leukemia and their dynamic regulation during all-trans retinoic acid treatment. Cell Death Dis. 2018;9(6):651. doi: 10.1038/s41419-018-0699-2
   PubMed Web of Science ®Google Scholar
• Pan Y, Lou J, Wang H, et al. CircBA9.3 supports the survival of leukaemic cells by up-regulating c-ABL1 or BCR-ABL1 protein levels. Blood Cells Mol Dis. 2018;73:38–44. doi: 10.1016/j.bcmd.2018.09.002
   PubMed Web of Science ®Google Scholar
• Liu J, Kong F, Lou S, et al. Global identification of circular RNAs in chronic myeloid leukemia reveals hsa_circ_0080145 regulates cell proliferation by sponging miR-29b. Biochem Biophys Res Commun. 2018;504(4):660–665. doi: 10.1016/j.bbrc.2018.08.154
   PubMed Web of Science ®Google Scholar
• Xia L, Wu L, Bao J, et al. Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway. Biochem Biophys Res Commun. 2018;503(1):385–390. doi: 10.1016/j.bbrc.2018.06.045
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liang W, Zhang P, et al. Circular RNAs: emerging cancer biomarkers and targets. J Exp Clin Cancer Res. 2017;36(1):152. doi: 10.1186/s13046-017-0624-z
   PubMed Web of Science ®Google Scholar
• Holdt LM, Kohlmaier A, Teupser D. Molecular roles and function of circular RNAs in eukaryotic cells. Cell Mol Life Sci. 2018;75(6):1071–1098. doi: 10.1007/s00018-017-2688-5
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang J, Li J, et al. CircRNA_014511 affects the radiosensitivity of bone marrow mesenchymal stem cells by binding to miR-29b-2-5p. Bosn J Basic Med Sci. 2019;19(2):155–163.
   PubMed Web of Science ®Google Scholar
• Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016;17(4):205–211. doi: 10.1038/nrm.2015.32
   PubMed Web of Science ®Google Scholar
• Zang J, Lu D, Xu A. The interaction of circRNAs and RNA binding proteins: an important part of circRNA maintenance and function. J Neurosci Res. 2018:1–11
   Web of Science ®Google Scholar
• Legnini I, Di TG, Rossi F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66(1):22–37. e9. doi: 10.1016/j.molcel.2017.02.017
   PubMed Web of Science ®Google Scholar
• Bonizzato A, Gaffo E, Te KG, et al. CircRNAs in hematopoiesis and hematological malignancies. Blood Cancer J. 2016;6(10):e483. doi: 10.1038/bcj.2016.81
   PubMed Web of Science ®Google Scholar
• Li X, Zhang J, Gao L, et al. MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit. Cell Death Differ. 2012;19(3):378–386. doi: 10.1038/cdd.2011.127
   PubMed Web of Science ®Google Scholar
• Ouyang YB, Lu Y, Yue S, et al. miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion. 2012;12(2):213–219. doi: 10.1016/j.mito.2011.09.001
   PubMed Web of Science ®Google Scholar
• Zhang X, Yu J, Zhao C, et al. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2. Biomed Pharmacother. 2019;109:2192–2202. doi: 10.1016/j.biopha.2018.11.074
   PubMed Web of Science ®Google Scholar
• Strotbek M, Schmid S, Sánchez-González I, et al. miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer. Int J Cancer. 2017;140(10):2310–2320. doi: 10.1002/ijc.30661
   PubMed Web of Science ®Google Scholar
• Lin Z, Li D, Cheng W, et al. MicroRNA-181 functions as an antioncogene and mediates NF-κB pathway by targeting RTKN2 in ovarian cancers. Reprod Sci. 2018;1933719118805865.
   Google Scholar
• Chen Y, Gao Y, Tian Y, et al. PRKACB is downregulated in non-small cell lung cancer and exogenous PRKACB inhibits proliferation and invasion of LTEP-A2 cells. Oncol Lett. 2013;5(6):1803–1808. doi: 10.3892/ol.2013.1294
   PubMed Web of Science ®Google Scholar
• Mrózek K. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype. Semin Oncol. 2008;35(4):365–377. doi: 10.1053/j.seminoncol.2008.04.007
   PubMed Web of Science ®Google Scholar
• Wang X, Zuo D, Yuan Y, et al. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia. J Cancer Res Clin Oncol. 2017;143(1):169–180. doi: 10.1007/s00432-016-2277-2
   PubMed Web of Science ®Google Scholar
• Zeng HF, Yan S, Wu SF. MicroRNA-153-3p suppress cell proliferation and invasion by targeting SNAI1 in melanoma. Biochem Biophys Res Commun. 2017;487(1):140–145. doi: 10.1016/j.bbrc.2017.04.032
   PubMed Web of Science ®Google Scholar
• Heider T, Mutschelknaus L, Radulović V, et al. Radiation induced transcriptional and post-transcriptional regulation of the hsa-miR-23a∼27a∼24-2 cluster suppresses apoptosis by stabilizing XIAP. Biochim Biophys Acta Gene Regul Mech. 2017;1860(11):1127–1137. doi: 10.1016/j.bbagrm.2017.08.006
   PubMed Web of Science ®Google Scholar
• Falini B, Nicoletti I, Bolli N, et al. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. Haematologica. 2007;92(4):519–532. doi: 10.3324/haematol.11007
   PubMed Web of Science ®Google Scholar
• Brunetti L, Gundry MC, Goodell MA. New insights into the biology of acute myeloid leukemia with mutated NPM1. Int J Hematol. 2019;110(2):150–160. doi: 10.1007/s12185-018-02578-7
   PubMed Web of Science ®Google Scholar
• Bock S, Murgueitio MS, Wolber G, et al. Acute myeloid leukaemia-derived Langerhans-like cells enhance Th1 polarization upon TLR2 engagement. Pharmacol Res. 2016;105:44–53. doi: 10.1016/j.phrs.2016.01.016
   PubMed Web of Science ®Google Scholar
• Shima Y, Honma Y, Kitabayashi I. PML-RARα and its phosphorylation regulate PML oligomerization and HIPK2 stability. Cancer Res. 2013;73(14):4278–4288. doi: 10.1158/0008-5472.CAN-12-3814
   PubMed Web of Science ®Google Scholar
• Hackanson B, Bennett KL, Brena RM, et al. Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. Cancer Res. 2008;68(9):3142–3151. doi: 10.1158/0008-5472.CAN-08-0483
   PubMed Web of Science ®Google Scholar
• Kogut N, Tsai NC, Thomas SH, et al. Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia. Leuk Lymphoma. 2013;54(3):665–668. doi: 10.3109/10428194.2012.720375
   PubMed Web of Science ®Google Scholar
• Lv C, Sun L, Guo Z, et al. Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration. J Transl Med. 2018;16(1):361. doi: 10.1186/s12967-018-1726-x
   PubMed Web of Science ®Google Scholar
• Shanmuganathan N, Hughes TP. Molecular monitoring in CML: how deep? How often? How should it influence therapy?. Blood. 2018;132(20):2125–2133. doi: 10.1182/blood-2018-05-848630
   PubMed Web of Science ®Google Scholar
• Kollinerova S, Vassanelli S, Modriansky M. The role of miR-29 family members in malignant hematopoiesis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(4):489–501. doi: 10.5507/bp.2014.029
   PubMed Web of Science ®Google Scholar
• Rossari F, Minutolo F, Orciuolo E. Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy. J Hematol Oncol. 2018;11(1):84. doi: 10.1186/s13045-018-0624-2
   PubMed Web of Science ®Google Scholar
• Salzman J, Chen RE, Olsen MN, et al. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9(9):e1003777. doi: 10.1371/journal.pgen.1003777
   PubMed Web of Science ®Google Scholar
• Franiak-Pietryga I, Maciejewski H, Ziemba B, et al. Blockage of Wnt/β-catenin signaling by nanoparticles reduces survival and proliferation of CLL cells in vitro-preliminary study. Macromol Biosci. 2017;17(11):1700130. doi: 10.1002/mabi.201700130
   Web of Science ®Google Scholar